Viewing Study NCT03310567


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-02-25 @ 5:52 PM
Study NCT ID: NCT03310567
Status: WITHDRAWN
Last Update Posted: 2018-10-09
First Post: 2017-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module